RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Mahavir Chougule to Humans

This is a "connection" page, showing publications Mahavir Chougule has written about Humans.
Connection Strength

0.560
  1. Kashikar R, Kotha AK, Shah S, Famta P, Singh SB, Srivastava S, Chougule MB. Advances in nanoparticle mediated targeting of RNA binding protein for cancer. Adv Drug Deliv Rev. 2022 06; 185:114257.
    View in: PubMed
    Score: 0.039
  2. Alexander A, Agrawal M, Saraf S, Saraf S, Chougule MB. Formulation Strategies of Nano Lipid Carrier for Effective Brain Targeting of Anti-AD Drugs. Curr Pharm Des. 2020; 26(27):3269-3280.
    View in: PubMed
    Score: 0.033
  3. Gandhi NS, Godeshala S, Koomoa-Lange DT, Miryala B, Rege K, Chougule MB. Bioreducible Poly(Amino Ethers) Based mTOR siRNA Delivery for Lung Cancer. Pharm Res. 2018 Aug 13; 35(10):188.
    View in: PubMed
    Score: 0.030
  4. Youngren-Ortiz SR, Chougule MB. The Daniel K. Inouye College of Pharmacy Scripts: Targeted Nanocarrier Based Systems for the Treatment of Lung Cancer. Hawaii J Med Public Health. 2017 11; 76(11):318-325.
    View in: PubMed
    Score: 0.029
  5. Youngren-Ortiz SR, Hill DB, Hoffmann PR, Morris KR, Barrett EG, Forest MG, Chougule MB. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer. J Aerosol Med Pulm Drug Deliv. 2017 Oct; 30(5):299-321.
    View in: PubMed
    Score: 0.027
  6. Chougule MB. Foreword. Prog Drug Res. 2016; 71:vii.
    View in: PubMed
    Score: 0.025
  7. Glasgow MD, Chougule MB. Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging. J Biomed Nanotechnol. 2015 Nov; 11(11):1859-98.
    View in: PubMed
    Score: 0.025
  8. Chougule MB, Tan C. Translational application of nano delivery systems: emerging cancer therapy. AAPS PharmSciTech. 2015 Feb; 16(1):3-4.
    View in: PubMed
    Score: 0.024
  9. Tekade RK, Youngren-Ortiz SR, Yang H, Haware R, Chougule MB. Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis. Mol Pharm. 2014 Oct 06; 11(10):3671-83.
    View in: PubMed
    Score: 0.023
  10. Gandhi NS, Tekade RK, Chougule MB. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. J Control Release. 2014 Nov 28; 194:238-56.
    View in: PubMed
    Score: 0.023
  11. Chougule MB, Patel AR, Patlolla R, Jackson T, Singh M. Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption. J Drug Target. 2014 Jul; 22(6):498-508.
    View in: PubMed
    Score: 0.022
  12. Youngren SR, Tekade RK, Gustilo B, Hoffmann PR, Chougule MB. STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cells. Biomed Res Int. 2013; 2013:858946.
    View in: PubMed
    Score: 0.022
  13. Tekade RK, Chougule MB. Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design. Biomed Res Int. 2013; 2013:712678.
    View in: PubMed
    Score: 0.022
  14. Chougule MB, Patel A, Sachdeva P, Jackson T, Singh M. Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer. PLoS One. 2011; 6(11):e27394.
    View in: PubMed
    Score: 0.019
  15. Chougule MB, Patel AR, Jackson T, Singh M. Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer. PLoS One. 2011 Mar 15; 6(3):e17733.
    View in: PubMed
    Score: 0.018
  16. Chougule M, Patel AR, Sachdeva P, Jackson T, Singh M. Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer. Lung Cancer. 2011 Mar; 71(3):271-82.
    View in: PubMed
    Score: 0.017
  17. Misra A, Jinturkar K, Patel D, Lalani J, Chougule M. Recent advances in liposomal dry powder formulations: preparation and evaluation. Expert Opin Drug Deliv. 2009 Jan; 6(1):71-89.
    View in: PubMed
    Score: 0.016
  18. Chougule MB, Padhi BK, Jinturkar KA, Misra A. Development of dry powder inhalers. Recent Pat Drug Deliv Formul. 2007; 1(1):11-21.
    View in: PubMed
    Score: 0.014
  19. Shah S, Famta P, Tiwari V, Kotha AK, Kashikar R, Chougule MB, Chung YH, Steinmetz NF, Uddin M, Singh SB, Srivastava S. Instigation of the epoch of nanovaccines in cancer immunotherapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023 May-Jun; 15(3):e1870.
    View in: PubMed
    Score: 0.010
  20. Shah S, Famta P, Bagasariya D, Charankumar K, Sikder A, Kashikar R, Kotha AK, Chougule MB, Khatri DK, Asthana A, Raghuvanshi RS, Singh SB, Srivastava S. Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer Therapy. Mol Pharm. 2022 12 05; 19(12):4428-4452.
    View in: PubMed
    Score: 0.010
  21. Harris HM, Boyet KL, Liu H, Dwivedi R, Ashpole NM, Tandon R, Bidwell GL, Cheng Z, Fassero LA, Yu CS, Pomin VH, Mitra D, Harrison KA, Dahl E, Gurley BJ, Kotha AK, Chougule MB, Sharp JS. Safety and Pharmacokinetics of Intranasally Administered Heparin. Pharm Res. 2022 Mar; 39(3):541-551.
    View in: PubMed
    Score: 0.010
  22. Shah S, Chougule MB, Kotha AK, Kashikar R, Godugu C, Raghuvanshi RS, Singh SB, Srivastava S. Nanomedicine based approaches for combating viral infections. J Control Release. 2021 10 10; 338:80-104.
    View in: PubMed
    Score: 0.009
  23. Shahin H, Vinjamuri BP, Mahmoud AA, Mansour SM, Chougule MB, Chablani L. Formulation and optimization of sildenafil citrate-loaded PLGA large porous microparticles using spray freeze-drying technique: A factorial design and in-vivo pharmacokinetic study. Int J Pharm. 2021 Mar 15; 597:120320.
    View in: PubMed
    Score: 0.009
  24. Bhatt P, Narvekar P, Lalani R, Chougule MB, Pathak Y, Sutariya V. An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration. AAPS PharmSciTech. 2019 Aug 09; 20(7):281.
    View in: PubMed
    Score: 0.008
  25. Shahin HI, Vinjamuri BP, Mahmoud AA, Shamma RN, Mansour SM, Ammar HO, Ghorab MM, Chougule MB, Chablani L. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension. J Control Release. 2019 05 28; 302:126-139.
    View in: PubMed
    Score: 0.008
  26. Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, Alexander A. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018 07 10; 281:139-177.
    View in: PubMed
    Score: 0.007
  27. Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, Shoyele SA, Gupta U, Alexander A. Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region. Expert Opin Drug Deliv. 2018 06; 15(6):589-617.
    View in: PubMed
    Score: 0.007
  28. Andey T, Patel A, Marepally S, Chougule M, Spencer SD, Rishi AK, Singh M. Formulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine. PLoS One. 2016; 11(1):e0146804.
    View in: PubMed
    Score: 0.006
  29. Aldawsari M, Chougule MB, Babu RJ. Progress in Topical siRNA Delivery Approaches for Skin Disorders. Curr Pharm Des. 2015; 21(31):4594-605.
    View in: PubMed
    Score: 0.006
  30. Patel AR, Chougule M, Singh M. EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer. Pharm Res. 2014 Oct; 31(10):2796-809.
    View in: PubMed
    Score: 0.006
  31. Patel AR, Chougule MB, Lim E, Francis KP, Safe S, Singh M. Theranostic tumor homing nanocarriers for the treatment of lung cancer. Nanomedicine. 2014 Jul; 10(5):1053-63.
    View in: PubMed
    Score: 0.005
  32. Patel AR, Chougule MB, I T, Patlolla R, Wang G, Singh M. Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel. Pharm Res. 2013 May; 30(5):1435-46.
    View in: PubMed
    Score: 0.005
  33. Patel AR, Spencer SD, Chougule MB, Safe S, Singh M. Pharmacokinetic evaluation and in vitro-in vivo correlation (IVIVC) of novel methylene-substituted 3,3' diindolylmethane (DIM). Eur J Pharm Sci. 2012 May 12; 46(1-2):8-16.
    View in: PubMed
    Score: 0.005
  34. Ichite N, Chougule M, Patel AR, Jackson T, Safe S, Singh M. Inhalation delivery of a novel diindolylmethane derivative for the treatment of lung cancer. Mol Cancer Ther. 2010 Nov; 9(11):3003-14.
    View in: PubMed
    Score: 0.004
  35. Ichite N, Chougule MB, Jackson T, Fulzele SV, Safe S, Singh M. Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res. 2009 Jan 15; 15(2):543-52.
    View in: PubMed
    Score: 0.004
  36. Patel G, Chougule M, Singh M, Misra A. Chapter 9 - Nanoliposomal dry powder formulations. Methods Enzymol. 2009; 464:167-91.
    View in: PubMed
    Score: 0.004
  37. Naik S, Chougule M, Padhi BK, Misra A. Development of novel lyophilized mixed micelle amphotericin B formulation for treatment of systemic fungal infection. Curr Drug Deliv. 2005 Apr; 2(2):177-84.
    View in: PubMed
    Score: 0.003
  38. Kalariya M, Padhi BK, Chougule M, Misra A. Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications. Indian J Exp Biol. 2005 Mar; 43(3):233-40.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support